RAS inhibitors: how a pancreatic cancer pill works
12 steps · about 2 h 24 min · Beginner
- Understanding Cancer (guide, National Cancer Institute, 15 min)
Start with the core idea that cancer is a disease of the genes that control how cells behave.
- The Genetics of Cancer (article, National Cancer Institute, 15 min)
It shows how random DNA changes pile up over time and turn healthy cells cancerous.
- How Genetic Changes Lead to Cancer (article, National Cancer Institute, 8 min)
It links genes to proteins and shows how a single mutation can change a protein's function, which is what happens to RAS.
- Cell Biology of Cancer (article, SEER Training Modules, 20 min)
It introduces oncogenes and tumor suppressors, so you know why a stuck-on switch like RAS is dangerous.
- KRAS and Lung Cancer (article, American Lung Association, 10 min)
A plain-language look at what KRAS does as a cell-growth signal hub and how mutations are tested for.
- Targeted Therapy (article, American Cancer Society, 15 min)
It explains how drugs aimed at specific cancer features differ from chemotherapy.
- FDA Approves Daraxonrasib (Rasonque) for Metastatic Pancreatic Cancer (article, WebMD, 8 min)
A patient-level summary of what the pill is, who it is for and how it differs from IV chemotherapy.
- New pancreatic cancer drug daraxonrasib shows breakthrough in survival (article, UCHealth Today, 8 min)
It explains in simple terms why RAS has been a hard target and why this drug is the first of a new class.
- Oncology Drug Reference Sheet: Daraxonrasib (reference, Oncology Nursing Society, 10 min)
It gives the molecular mechanism: the drug binds cyclophilin A, and that complex locks onto active RAS.
- Dr Aguirre on Daraxonrasib Bringing RAS-Targeted Therapy to Pancreatic Cancer (article, Targeted Oncology, 10 min)
A researcher explains the molecular-glue idea and the path from preclinical work to phase 3.
- How to Read Cancer Trial Results: Survival Terms Explained (article, CURE Today, 10 min)
It teaches trial phases, median survival, progression-free survival and hazard ratios before you read the real paper.
- How to Read a Clinical Trial: Hazard Ratios and Kaplan-Meier Curves (article, FTLO Science, 15 min)
It deepens your statistics skills with survival curves and the limits of hazard ratios.